Drug Interactions between asenapine and Mono-Linyah
This report displays the potential drug interactions for the following 2 drugs:
- asenapine
- Mono-Linyah (ethinyl estradiol/norgestimate)
Interactions between your drugs
ethinyl estradiol asenapine
Applies to: Mono-Linyah (ethinyl estradiol / norgestimate) and asenapine
Consumer information for this interaction is not currently available.
MONITOR: Coadministration with inhibitors of CYP450 1A2 may increase the plasma concentrations of asenapine, which is partially metabolized by the isoenzyme. According to the product labeling, administration of asenapine (5 mg single dose) in combination with the potent CYP450 1A2 inhibitor fluvoxamine (25 mg twice daily for 8 days) resulted in a 13% increase in asenapine peak plasma concentration (Cmax) and a 29% increase in systemic exposure (AUC). The full therapeutic dose of fluvoxamine would be expected to cause a greater increase in asenapine plasma concentrations.
MANAGEMENT: Caution is advised if asenapine is prescribed in combination with CYP450 1A2 inhibitors. Pharmacologic response to asenapine should be monitored more closely whenever a CYP450 1A2 inhibitor is added to or withdrawn from therapy, and the asenapine dosage adjusted as necessary.
Drug and food interactions
norgestimate food
Applies to: Mono-Linyah (ethinyl estradiol / norgestimate)
Grapefruit juice may increase the blood levels of certain medications such as norgestimate. You may want to limit your consumption of grapefruit and grapefruit juice during treatment with norgestimate. However, if you have been regularly consuming grapefruit or grapefruit juice with the medication, then it is advisable for you to talk with your doctor before changing the amounts of these products in your diet, as this may alter the effects of your medication. Contact your doctor if your condition changes or you experience increased side effects. Orange juice is not expected to interact.
asenapine food
Applies to: asenapine
Alcohol can increase the nervous system side effects of asenapine such as dizziness, drowsiness, and difficulty concentrating. Some people may also experience impairment in thinking and judgment. You should avoid or limit the use of alcohol while being treated with asenapine. Do not use more than the recommended dose of asenapine, and avoid activities requiring mental alertness such as driving or operating hazardous machinery until you know how the medication affects you. Talk to your doctor or pharmacist if you have any questions or concerns.
ethinyl estradiol food
Applies to: Mono-Linyah (ethinyl estradiol / norgestimate)
Consumer information for this interaction is not currently available.
MONITOR: Coadministration of ethinyl estradiol may increase the plasma concentrations of drugs that are primarily metabolized by CYP450 1A2. In a study of 30 healthy volunteers administered the CYP450 1A2 substrate tizanidine, the systemic exposure (AUC) of tizanidine was 3.9 times greater in women using an oral contraceptive containing ethinyl estradiol.
MANAGEMENT: Patients should be monitored for increased adverse effects of the CYP450 1A2 substrate during concomitant use with ethinyl estradiol. Product labeling for the specific CYP450 1A2 substrate should be consulted for additional recommendations.
ethinyl estradiol food
Applies to: Mono-Linyah (ethinyl estradiol / norgestimate)
Information for this minor interaction is available on the professional version.
ethinyl estradiol food
Applies to: Mono-Linyah (ethinyl estradiol / norgestimate)
Information for this minor interaction is available on the professional version.
Therapeutic duplication warnings
No warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
See also
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.